PURPOSE OF REVIEW: The purpose of this study was to review the literature on the relationship between migraine, anxiety and related disorders, anxious symptomology and related behaviors. RECENT FINDINGS: Generalized anxiety, other anxious disorders and migraine are comorbid. In addition, anxious symptomology and behaviors are common in people with migraine even if they do not meet diagnostic criteria or threshold. Anxiety including diagnosed disorders such as generalized anxiety, phobias, panic disorder, as well as behaviors such as catastrophizing, avoidance behaviors, and higher fear of headache/migraine or anxiety sensitivity are comorbid and/or common in migraine. Anxiety is associated with negative outcomes such as migraine progression, medication overuse, stigma and migraine-related disability. The association between migraine, anxiety, and fear and avoidance behaviors has an extensive empirical basis. Awareness of the high prevalence of comorbidity and symptomology as well as the negative outcomes associated with anxiety and related symptoms and behaviors is important in the comprehensive management of people with migraine. Better understanding the relationship between migraine and anxiety symptoms and behaviors and their effects on outcomes is essential to provide more effective treatment for people with migraine. The review emphasizes the necessity of screening and more comprehensive evaluation in patients with migraine using psychological diagnostic tools. Thus, prevention and management of anxiety, fear, and anxiety-related behaviors in the context of migraine management may be considered an essential treatment goal and strategies may include non-pharmacological and pharmacological approaches.

Department of Clinical Psychology University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine Prague Czech Republic

Department of Neurology Albert Einstein College of Medicine Yeshiva University Bronx NY USA

Department of Nursing 2Nd Faculty of Medicine Charles University Prague Czech Republic

See more in PubMed

Safiri S, Pourfathi H, Eagan A, Mansournia MA, Khodayari MT, Sullman MJM, Kaufman J, Collins G, Dai H, Bragazzi NL, Kolahi AA. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain. 2022;163(2):e293–309. 10.1097/j.pain.0000000000002275. PubMed

Sayers J. The world health report 2001-Mental health: new understanding, new hope. Bull World Health Organ. 2001;79(11):1085.

Raggi A, Giovannetti AM, Quintas R, D’Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain. 2012;13(8):595–606. 10.1007/s10194-012-0482-1. PubMed PMC

Dresler T, Caratozzolo S, Guldolf K, Huhn JI, Loiacono C, Niiberg-Pikksööt T, Puma M, Sforza G, Tobia A, Ornello R, Serafini G. European Headache Federation School of Advanced Studies (EHF-SAS) Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J Headache Pain. 2019;20(1):51. 10.1186/s10194-019-0988-x. PubMed PMC

Philips HC, Jahanshahi M. The components of pain behaviour report. Behav Res Ther. 1986;24(2):117–25. 10.1016/0005-7967(86)90082-3. PubMed

Peres MF, Mercante JP, Tobo PR, Kamei H, Bigal ME. Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain. 2017;18(1):37. 10.1186/s10194-017-0742-1. PubMed PMC

Smitherman TA, Penzien DB, Maizels M. Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep. 2008;12(3):224–9. 10.1007/s11916-008-0039-9. PubMed

Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. PubMed PMC

Rogers DG, Protti TA, Smitherman TA. Fear, avoidance, and disability in headache disorders. Curr Pain Headache Rep. 2020;29:33. 10.1007/s11916-020-00865-9. PubMed

Smitherman TA, Kolivas ED, Bailey JR. Panic disorder and migraine: comorbidity, mechanisms, and clinical implications. Headache. 2013;53(1):23–45. 10.1111/head.12004. PubMed

Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R, Silbersweig D. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016;87(7):741–9. PubMed

Luo J. Association between migraine and anxiety symptoms: Results from the study of women’s health across the nation. J Affect Disord. 2021;295:1229–33. PubMed

Blau JN. Fears aroused in patients by migraine. Br Med J (Clin Res Ed). 1984;288(6424):1126. 10.1136/bmj.288.6424.1126. PubMed PMC

Rutberg S, Öhrling K. Migraine – more than a headache: women’s experiences of living with migraine. Disabil Rehabil. 2012;34(4):329–36. 10.3109/09638288.2011.607211. PubMed PMC

Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2007;48(1):16–25. 10.1111/j.1526-4610.2007.00970.x. PubMed

Lantéri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: Influence on migraine subjectsʼ disability and quality of life, and acute migraine management. Pain. 2005;118(3):319–26. 10.1016/j.pain.2005.09.010. PubMed

Pesa J, Lage MJ. The medical costs of migraine and comorbid anxiety and depression. Headache. 2004;44(6):562–70. 10.1111/j.1526-4610.2004.446004.x. PubMed

Guidetti V, Galli F, Fabrizi P, Giannantoni AS, Napoli L, Bruni O, Trillo S. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998;18(7):455–62. 10.1046/j.1468-2982.1998.1807455.x. PubMed

Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: a systematic review. Headache. 2019;59(3):306–38. 10.1111/head.13459. PubMed

Reme SE. Anxiety could play a larger role than depression in migraine headache. Scand J Pain. 2016;13(1):127. 10.1016/j.sjpain.2016.08.002. PubMed

Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia. 2005;25(3):165–78. 10.1111/j.1468-2982.2004.00839.x. PubMed

Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998;18(Suppl 22):56–8. PubMed

Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32. PubMed

Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the american migraine prevalence and prevention (AMPP) study. Headache. 2020. 10.1111/head.13966. PubMed

Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. 10.1186/s10194-020-1084-y. PubMed PMC

Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM. Headache types and panic disorder: directionality and specificity. Neurology. 2001;56(3):350–4. 10.1212/wnl.56.3.350. PubMed

Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults. Psychiatry Res. 1991;37(1):11–23. 10.1016/0165-1781(91)90102-u. PubMed

Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: A prospective epidemiologic study in young adults. J Psychiatr Res. 1993;27(2):211–21. 10.1016/0022-3956(93)90009-q. PubMed

Zhang M, Liu Y, Zhao M, Tang W, Wang X, Dong Z, Yu S. Depression and anxiety behaviour in a rat model of chronic migraine. J Headache Pain. 2017;18(1):27. 10.1186/s10194-017-0736-z. PubMed PMC

Green MW. Headaches: psychiatric aspects. Neurol Clin. 2011;29(1):65–vii. 10.1016/j.ncl.2010.10.004. PubMed

Baldacci F, Lucchesi C, Cafalli M, Poletti M, Ulivi M, Vedovello M, Giuntini M, Mazzucchi S, Del Prete E, Vergallo A, Nuti A, Gori S. Migraine features in migraineurs with and without anxiety-depression symptoms: a hospital-based study. Clin Neurol Neurosurg. 2015;132:74–8. 10.1016/j.clineuro.2015.02.017. PubMed

Noseda R, Kainz V, Borsook D, Burstein R. Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxiety. PLoS ONE. 2014;9(8):e103929. 10.1371/journal.pone.0103929. PubMed PMC

Vlaeyen JWS, Crombez G, Linton SJ. The fear-avoidance model of pain. Pain. 2016;157(8):1588–9. 10.1097/j.pain.0000000000000574. PubMed

Mittinty MM, McNeil DW, Brennan DS, Randall CL, Mittinty MN, Jamieson L. Assessment of pain-related fear in individuals with chronic painful conditions. J Pain Res. 2018;11:3071–7. 10.2147/JPR.S163751. PubMed PMC

Chen Z, Chen X, Liu M, Ma L, Yu S. Lower hippocampal subfields volume in relation to anxiety in medication-overuse headache. Mol Pain. 2018;14:174480691876125. 10.1177/1744806918761257. PubMed PMC

Helsen K, Leeuw M, Vlaeyen J. Fear and Pain. In: Gebhart GF, Schmidt RF, editors. Encyclopedia of Pain. Berlin: Springer; 2013. p. 1261–7.

Zale EL, Lange KL, Fields SA, Ditre JW. The relation between pain-related fear and disability: a meta-analysis. J Pain. 2013;14(10):1019–30. 10.1016/j.jpain.2013.05.005. PubMed PMC

Asmundson GJ, Norton PJ, Veloso F. Anxiety sensitivity and fear of pain in patients with recurring headaches. Behav Res Ther. 1999;37(8):703–13. 10.1016/s0005-7967(98)00172-7. PubMed

Hursey KG, Jacks SD. Fear of pain in recurrent headache sufferers. Headache. 1992;32(6):283–6. 10.1111/j.1526-4610.1992.hed3206283.x. PubMed

Ruscheweyh R, Pereira D, Hasenbring MI, Straube A. Pain-related avoidance and endurance behaviour in migraine: an observational study. J Headache Pain. 2019;20(1):9. 10.1186/s10194-019-0962-7. PubMed PMC

Rogers DG, Protti TA, Smitherman TA. Fear, avoidance, and disability in headache disorders. Curr Pain Headache Rep. 2020;24:33. 10.1007/s11916-020-00865-9. PubMed

van Tulder MW, Ostelo R, Vlaeyen JW, Linton SJ, Morley SJ, Assendelft WJ. Behavioral treatment for chronic low back pain: a systematic review within the framework of the Cochrane Back Review Group. Spine. 2000;25(20):2688–99. 10.1097/00007632-200010150-00024. PubMed

Hasenbring M, Verbunt JA. Fear-avoidance and endurance-related responses to pain: new models of behavior and their consequences for clinical practice. Clin J Pain. 2010;26(9):747–53. 10.1097/AJP.0b013e3181e104f2. PubMed

Black AK, Fulwiler JC, Smitherman TA. The role of fear of pain in headache. Headache. 2015;55(5):669–79. 10.1111/head.12561. PubMed

Mongini F, Fassino S, Rota E, Deregibus A, Levi M, Monticone D, Abbate-Daga G. The temperament and character inventory in women with migraine. J Headache Pain. 2005;6(4):247–9. 10.1007/s10194-005-0198-6. PubMed PMC

Anxiety sensitivity. In: Harvard Health Publishing. 2014. https://www.health.harvard.edu/newsletter_article/Anxiety_sensitivity. Accessed:15 Jan 2023.

Farris SG, Burr EK, Abrantes AM, Thomas JG, Godley FA, Roth JL, Lipton RB, Pavlovic JM, Bond DS. Anxiety sensitivity as a risk indicator for anxiety, depression, and headache severity in women with migraine. Headache. 2019;59(8):1212–20. 10.1111/head.13568. PubMed

Farris SG, Thomas JG, Abrantes AM, Lipton RB, Burr EK, Godley FA, Roth JL, Pavlovic JM, Bond DS. Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine. Cephalalgia. 2019;39(11):1465–9. 10.1177/0333102419861712. PubMed

Asmundson GJ, Taylor S. Role of anxiety sensitivity in pain-related fear and avoidance. J Behav Med. 1996;19(6):577–86. 10.1007/bf01904905. PubMed

Norton PJ, Asmundson GJ. Anxiety sensitivity, fear, and avoidance behavior in headache pain. Pain. 2004;111(1–2):218–23. 10.1016/j.pain.2004.06.018. PubMed

Smitherman TA, Davis RE, Walters AB, Young J, Houle TT. Anxiety sensitivity and headache: diagnostic differences, impact, and relations with perceived headache triggers. Cephalalgia. 2014;35(8):710–21. 10.1177/0333102414557840. PubMed

Fiske DW. Consistency of the factorial structures of personality ratings from different add to the citing literature sources. Psychol Sci Public Interest. 1949;44(3):329–44. 10.1037/h0057198. PubMed

Davis RE, Smitherman TA, Baskin SM. Personality traits, personality disorders, and migraine: a review. Neurol Sci. 2013;34(1):7–10. 10.1007/s10072-013-1379-8. PubMed

Balottin U, Fusar Poli P, Termine C, Molteni S, Galli F. Psychopathological symptoms in child and adolescent migraine and tension-type headache: a meta-analysis. Cephalalgia. 2012;33(2):112–22. 10.1177/0333102412468386. PubMed

Lake AE, Rains JC, Penzien DB, Lipchik GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache. 2005;45(5):493–506. 10.1111/j.1526-4610.2005.05101.x. PubMed

Rothrock J, Lopez I, Zweilfer R, Andress-Rothrock D, Drinkard R, Walters N. Borderline personality disorder and migraine. Headache. 2007;47(1):22–6. 10.1111/j.1526-4610.2007.00649.x. PubMed

Yang F, Dos Santos IAM, Gomez RS, Kummer A, Barbosa IG, Teixeira AL. Personality disorders are associated with more severe forms of migraine. Acta Neurol Belg. 2019;119(2):201–5. 10.1007/s13760-018-1050-5. PubMed

Saper JR, Lake AE 3rd. Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache. 2002;42(7):663–74. 10.1046/j.1526-4610.2002.02156.x PubMed

Schwedt TJ, Buse DC, Argoff CE, Reed ML, Fanning KM, Hussar CR, Adams AM, Lipton RB. Medication overuse and headache burden: results from the cameo study. Neurol Clin Pract. 2021;11(3):216–26. 10.1212/CPJ.0000000000001037. PubMed PMC

Sances G, Galli F, Anastasi S, Ghiotto N, De Giorgio G, Guidetti V, Firenze C, Pazzi S, Quartesan R, Gallucci M, Nappi G. Medication-overuse headache and personality: a controlled study by means of the MMPI-2. Headache. 2010;50(2):198–209. 10.1111/j.1526-4610.2009.01593.x. PubMed

Bottiroli S, Galli F, Viana M, Sances G, Tassorelli C. Traumatic experiences, stressful events, and alexithymia in chronic migraine with medication overuse. Front Psychol. 2018;9:704. 10.3389/fpsyg.2018.00704. PubMed PMC

Galli F, Caputi M, Sances G, Vegni E, Bottiroli S, Nappi G, Tassorelli C. Alexithymia in chronic and episodic migraine: a comparative study. J Ment Health. 2017;26(3):192–6. 10.3109/09638237.2015.1124404. PubMed

Frith U. Emanuel Miller lecture: Confusions and controversies about Asperger syndrome. J Child Psychol Psychiatry. 2004;45(4):672–86. 10.1111/j.1469-7610.2004.00262.x. PubMed

Tani P, Lindberg N, Joukamaa M, Nieminen-von Wendt T, von Wendt L, Appelberg B, Rimón R, Porkka-Heiskanen T. Asperger syndrome, alexithymia and perception of sleep. Neuropsychobiology. 2004;49(2):64–70. 10.1159/000076412. PubMed

Merikangas KR, Angst J, Isler H. Migraine and psychopathology: results of the Zurich cohort study of young adults. Arch Gen Psychiatry. 1990;47(9):849–53. 10.1001/archpsyc.1990.01810210057008. PubMed

Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression isassociated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med. 1998;4(1):14–21. 10.1007/BF03401725. PubMed PMC

Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore epidemiologic catchment area follow-up study. Arch Gen Psychiatry. 2000;57(10):945. 10.1001/archpsyc.57.10.945. PubMed

Peres MF, Mercante JP, Guendler VZ, Corchs F, Bernik MA, Zukerman E, Silberstein SD. Cephalalgiaphobia: a possible specific phobia of illness. J Headache Pain. 2007;8(1):56–9. 10.1007/s10194. PubMed PMC

Giannini G, Zanigni S, Grimaldi D, Melotti R, Pierangeli G, Cortelli P, Cevoli S. Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study. J Headache Pain. 2013;14(1):1–6. 10.1186/1129-2377-14-49. PubMed PMC

Miller TW, Kraus RF. An overview of chronic pain. Hosp Community Psychiatry. 1990;41(4):433–40. PubMed

Martelli MF, Grayson RL, Zasler ND. Posttraumatic headache: neuropsychological and psychological effects and treatment implications. J Head Trauma Rehabil. 1999;14(1):49–69. PubMed

Seng EK. Cogniphobia in Migraine: Fear and Avoidance of Thinking. In: Neurology advisor. 2017. https://www.neurologyadvisor.com/topics/migraine-and-headache/cogniphobia-in-migraine-the-fear-and-avoidance-of-thinking/. Accessed 15 Jan 2023.

Todd DD, Martelli MF, Grayson RL. The cogniphobia scale (C-Scale): a measure of headache impact. Test in the public domain. 1998. http://villamartelli.com/nanposters1999.htm.

Seng EK, Klepper JE. Development of the Cogniphobia Scale for headache disorders (CS-HD): a pilot study. Psychol Assess. 2017;29(10):1296–301. 10.1037/pas0000432. PubMed PMC

Martin PR, Reece J, Callan M, MacLeod C, Kaur A, Gregg K, Goadsby PJ. Behavioral management of the triggers of recurrent headache: a randomized controlled trial. Behav Res Ther. 2014;61:1–11. 10.1016/j.brat.2014.07.002. PubMed

Martin PR. Behavioral management of migraine headache triggers: learning to cope with triggers. Curr Pain Headache Rep. 2010;14(3):221–7. 10.1007/s11916-010-0112-z. PubMed

Suhr J, Spickard B. Pain-related fear is associated with cognitive task avoidance: exploration of the cogniphobia construct in a recurrent headache sample. Clin Neuropsychol. 2012;26(7):1128–41. 10.1080/13854046.2012.713121. PubMed

Karimi L, Wijeratne T, Crewther SG, Evans AE, Ebaid D, Khalil H. The migraine-anxiety comorbidity among migraineurs: a systematic review. Front Neurol. 2021;11:613372. 10.3389/fneur.2020.613372. PubMed PMC

Kumar R, Asif S, Bali A, Dang AK, Gonzalez DA. The development and impact of anxiety with migraines: a narrative review. Cureus. 2022;14(6):e26419. 10.7759/cureus.26419. PubMed PMC

Klan T, Bräscher AK, Klein S, Diezemann-Prößdorf A, Guth AL, Gaul C, Witthöft M. Assessing attack-related fear in headache disorders-Structure and psychometric properties of the Fear of Attacks in Migraine Inventory. Headache. 2022;62(3):294–305. 10.1111/head.14272. PubMed

Kubik SU, Martin PR. The Headache Triggers Sensitivity and Avoidance Questionnaire: Establishing the Psychometric Properties of the Questionnaire. Headache. 2017;57(2):236–54. PubMed

Caroli A, Klan T, Gaul C, Kubik SU, Martin PR, Witthöft M. Types of triggers in migraine - factor structure of the headache triggers sensitivity and avoidance questionnaire and development of a new short form (HTSAQ-SF). Headache. 2020;60(9):1920–9. 10.1111/head.13896. PubMed

Hamer JD, Sackey ET, Maack DJ, Smitherman TA. Development of a measure to assess acceptance of headache: The Headache Acceptance Questionnaire (HAQ). Cephalalgia. 2020;40(8):797–807. 10.1177/0333102420907596. PubMed

Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7. 10.1001/archinte.166.10.1092. PubMed

Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–21. 10.1176/appi.psy.50.6.613. PubMed

Lipton RB, Fanning KM, Buse DC, Martin VT, Hohaia LB, Adams AM, Reed ML, Goadsby PJ. Migraine progression in subgroups of migraine based on comorbidities: results of the CaMEO study. Neurology. 2019;93:e2224–36. PubMed PMC

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5. PubMed

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70. 10.1111/j.1600-0447.1983.tb09716.x. PubMed

Alvarez-Astorga A, García-Azorín D, Hernández M, de la Red H, Sotelo E, Uribe F, Guerrero AL. Pain catastrophising in a population of patients with migraine. Neurologia (Engl Ed). 2021;36(1):24–28. English, Spanish. 10.1016/j.nrl.2018.10.005 PubMed

Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–32. 10.1037/1040-3590.7.4.524.

Seng EK, Shapiro RE, Buse DC, Robbins MS, Lipton RB, Parker A. The unique role of stigma in migraine-related disability and quality of life. Headache. 2022;62(10):1354–2136. PubMed

Shapiro RE, Nicholson RA, Seng EK, Buse DC, Reed ML, Zagar AJ, Ashina S, Muenzel EJ, Hutchinson S, Pearlman EM, Lipton RB. Migraine-related stigma and its relationship to disability, interictal burden, and quality of life: results of the OVERCOME (US) Study. Neurology. 2024;102(3):e208074. PubMed PMC

Lipton RB, Seng EK, Chu MK, Reed ML, Fanning KM, Adams AM, Buse DC. The effect of psychiatric comorbidities on headache-related disability in migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) Study. Headache. 2020;60(8):1683–96. PubMed PMC

Seng EK, Buse DC, Klepper JE, Mayson JS, Grinberg AS, Grosberg BM, Pavlovic JM, Robbins MS, Vollbracht SE, Lipton RB. Psychological factors associated with chronic migraine and severe migraine-related disability: an observational study in a tertiary headache center. Headache. 2017;57(4):593–604. 10.1111/head.13021. PubMed PMC

Lipton RB, Buse DC, Dodick DW, Schwedt TJ, Singh P, Munjal S, Fanning K, Bostic Bs R, Reed ML. Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study. Headache. 2021;61(1):103–16. PubMed

Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC, Dodick DW, Lipton RB. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018;19(1):38. PubMed PMC

Yalug I, Selekler M, Erdogan A, Kutlu A, Dundar G, Ankarali H, Aker T. Correlations between alexithymia and pain severity, depression, and anxiety among patients with chronic and episodic migraine. Psychiatry Clin Neurosci. 2010;64(3):231–8. 10.1111/j.1440-1819.2010.02093.x. PubMed

Beehler GP, Conrad ML, Dimoff J, Haslam A Murphy J. Brief cognitive behavioral therapy for chronic pain: patient guidebook. Washington, DC: U.S. Department of Veterans Affairs; 2021.

Thorn, BE. Cognitive therapy for chronic pain, a step-by-step guide. New York, NY: Guilford Press; 2017.

Rogers DG, Protti TA, Smitherman TA. Fear, Avoidance, and Disability in Headache Disorders. Curr Pain Headache Rep. 2020;24(7):33. 10.1007/s11916-020-00865-9. PubMed

Black AK, Fulwiler JC, Smitherman TA. The role of fear of pain in headache. Headache. 2015;55(5):669–79. 10.1111/head.12561. PubMed

Smitherman TA, Davis RE, Walters AB, Young J, Houle TT. Anxiety sensitivity and headache: diagnostic differences, impact, and relations with perceived headache triggers. Cephalalgia. 2015;35(8):710–21. 10.1177/0333102414557840. PubMed

Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. 10.1186/s10194-020-1084-y. PubMed PMC

Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260(8):1960–9. 10.1007/s00415-012-6725-x. PubMed

Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R, Silbersweig D. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016;87(7):741–9. 10.1136/jnnp-2015-312233. PubMed